Abstracts - faqs.org

Abstracts

Mass communications

Search abstracts:
Abstracts » Mass communications

Drama from a crisis

Article Abstract:

The efforts of channel 4 in filming the drama 'The Government Inspector' in Iraq are discussed. The problems faced by the research team in Hutton inquiry are detailed.

Author: Chinn, Simon
Publisher: EMAP Maclaren Ltd.
Publication Name: Broadcast
Subject: Mass communications
ISSN: 0040-2788
Year: 2005
United States, Television programs, Channel 4 Television Co., Television dramas, The Government Inspector (Television program)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The mavericks of comedy

Article Abstract:

The efforts of channel Five to broadcast a comedy program, Swinging, written by Will Macdonald and David Granger's is discussed.

Author: Jardine, Alexandra
Publisher: EMAP Maclaren Ltd.
Publication Name: Broadcast
Subject: Mass communications
ISSN: 0040-2788
Year: 2005
United Kingdom, Works, Television comedies, Comedy programs, Channel Five Holdings Ltd., Swinging (Television program), Macdonald, Will, Granger, David

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Production management, Television broadcasting industry
Similar abstracts:
  • Abstracts: ITV in-house target shocks indie sector. New CBBC show inspired by Little Britain
  • Abstracts: Kudos set to take Spooks interactive. C4 utilises web to reach out to teens
  • Abstracts: ITV beats share drop with hopes for CRR. Market positive over ITV strategy update. RDF lifted by ITV's vote of confidence
  • Abstracts: Diverse to invest Zodiak cash in indie start-ups. Guerrilla Group goes into administration
  • Abstracts: Xtra Factor boosts ITV2 share. ITV gains from rugby scrum. Standing out amid the clutter
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.